Stock ANZU.U ANZU SPECIAL ACQUISITION CORP I
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Anzu Special Acquisition Corp I Share Price Nasdaq

Equities

ANZU.U

US03737A2006

Financials

Sales 2021 - Sales 2022 - Capitalization 532M 44.38B
Net income 2021 - 0 Net income 2022 19M 1.58B EV / Sales 2021 -
Net cash position 2021 150K 12.49M Net Debt 2022 1.39M 116M EV / Sales 2022 -
P/E ratio 2021
-1,773 x
P/E ratio 2022
27.7 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 0%
More Fundamentals * Assessed data

Chart Anzu Special Acquisition Corp I

Dynamic Chart

Latest news about Anzu Special Acquisition Corp I

Anzu Special Acquisition Corp I(NasdaqCM:ANZU) dropped from NASDAQ Composite Index CI
Envoy Medical Corporation completed the acquisition of Anzu Special Acquisition Corp I from Anzu SPAC GP I LLC and others in a reverse merger transaction. CI
Anzu Special Acquisition Approves Business Combination With Envoy Medical MT
Anzu Special Acquisition Corp I Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Anzu Special Acquisition Corp I Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Anzu Special Acquisition Corp I Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Anzu Special Acquisition Corp I Auditor Raises 'Going Concern' Doubt CI
Envoy Medical Corporation entered into a letter of intent to acquire Anzu Special Acquisition Corp I in a reverse merger transaction for approximately $150 million. CI
Anzu Special Acquisition Corp I Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Anzu Special Acquisition Corp I Appoints Daniel J. Hirsch as Chief Financial Officer CI
Anzu Special Acquisition Corp I Announces Management Changes CI
Anzu Special Acquisition Corp I Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Anzu Special Acquisition Corp I Announces Executive Changes CI
Anzu Special Acquisition Corp I Announces the Resignation of John W. Joy as Chief Financial Officer CI
Anzu Special Acquisition Corp I Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news

Press releases Anzu Special Acquisition Corp I

Breakthrough Hearing Health Technology Firm, Envoy Medical Begins Trading On NASDAQ NE
Envoy Medical Corporation and Anzu Special Acquisition Corp I Complete Business Combination NE
Envoy Medical Announces Shareholder Approval on Proposed Merger with Anzu Special Acquisition Corp I NE
Anzu Special Acquisition Corp I Stockholders Approve Business Combination with Envoy Medical Corporation BU
Envoy Medical Announces Proposed Board Slate of Experienced Medical Device and Financial Leaders NE
More press releases

Company Profile

Anzu Special Acquisition Corp I is a blank check company. The Company is created for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company focuses on transformative technologies for industrial applications. The Company has no operations and has not generated revenues.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. ANZU Stock
  4. ANZU.U Stock